Oslo - Delayed Quote NOK

Lytix Biopharma AS (LYTIX.OL)

Compare
6.00 -0.10 (-1.64%)
At close: 4:25 PM GMT+2

Valuation Measures

Annual
Monthly
Currency in NOK
Download
Current6/30/20243/31/202412/31/20239/30/20236/30/20233/31/2023
Market Cap 302.62M 452.45M 244.42M 194.73M 274.47M 290.50M --
Enterprise Value 245.44M 426.52M 165.65M 115.97M 174.25M 164.12M --
Trailing P/E -- -- -- -- -- -- --
Forward P/E -- -- -- -- -- -- --
PEG Ratio (5yr expected) -- -- -- -- -- -- --
Price/Sales 17.93 31.17 61.24 48.79 185.08 206.17 --
Price/Book 5.11 13.40 3.54 2.82 3.19 2.49 --
Enterprise Value/Revenue 16.99 29.38 41.51 29.06 117.50 116.48 --
Enterprise Value/EBITDA -2.06 -- -- -12.02 -9.36 -4.81 -4.88
3/31/2023 - 6/14/2021

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2023
Most Recent Quarter (mrq) 6/30/2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm) -543.01%

Management Effectiveness

Return on Assets (ttm) -53.28%
Return on Equity (ttm) -105.16%

Income Statement

Revenue (ttm) 14.44M
Revenue Per Share (ttm) 0.34
Quarterly Revenue Growth (yoy) --
Gross Profit (ttm) --
EBITDA -78.36M
Net Income Avi to Common (ttm) -76.42M
Diluted EPS (ttm) -1.79
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) 60.18M
Total Cash Per Share (mrq) 1.21
Total Debt (mrq) 3M
Total Debt/Equity (mrq) 5.06%
Current Ratio (mrq) 4.61
Book Value Per Share (mrq) 1.19

Cash Flow Statement

Operating Cash Flow (ttm) -87.16M
Levered Free Cash Flow (ttm) -58.68M

Trading Information

Stock Price History

Beta (5Y Monthly) -0.52
52 Week Range 3 -12.23%
S&P 500 52-Week Change 3 39.07%
52 Week High 3 15.00
52 Week Low 3 4.60
50-Day Moving Average 3 8.36
200-Day Moving Average 3 7.39

Share Statistics

Avg Vol (3 month) 3 103.16k
Avg Vol (10 day) 3 53.4k
Shares Outstanding 5 49.61M
Implied Shares Outstanding 6 50.1M
Float 8 25.02M
% Held by Insiders 1 41.74%
% Held by Institutions 1 0.00%
Shares Short 4 --
Short Ratio 4 --
Short % of Float 4 --
Short % of Shares Outstanding 4 --
Shares Short (prior month ) 4 --

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 0.00%
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq?=?Most Recent Quarter
  • ttm?=?Trailing Twelve Months
  • yoy?=?Year Over Year
  • lfy?=?Last Fiscal Year
  • fye?=?Fiscal Year Ending

Related Tickers